United States v. Duris

881 F. Supp. 2d 675, 2012 U.S. Dist. LEXIS 107325, 2012 WL 3114728
CourtDistrict Court, E.D. Pennsylvania
DecidedAugust 1, 2012
DocketNos. 11-cr-573, 11-cr-580, 11-cr-582, 11-cr-583
StatusPublished

This text of 881 F. Supp. 2d 675 (United States v. Duris) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Duris, 881 F. Supp. 2d 675, 2012 U.S. Dist. LEXIS 107325, 2012 WL 3114728 (E.D. Pa. 2012).

Opinion

MEMORANDUM OPINION

TIMOTHY R. RICE, United States Magistrate Judge.

As described by its own director of security, the Boeing Company’s Ridley Park facility was a mess five years ago. Some work areas were openly littered with drug paraphernalia. Special Agent Raymond Carr of the Federal Bureau of Investigation (“FBI”) described prescription drug abuse among Boeing workers as an “epidemic.” To make matters worse, Boeing apparently was unable to negotiate a collective bargaining agreement with the United Auto Workers Union (“UAW”) that would have allowed it to randomly test employees for prescription drug abuse on the job.1

All of this transpired while the United States was fighting a war on two fronts-our nation’s most expansive military initiative since World War II. As U.S. soldiers sacrificed their lives in battle, Boeing workers — some of whom were trafficking in, and abusing, prescription drugs on the job — were manufacturing some of the most sophisticated helicopter weaponry in the world: the V-22 Osprey and the CH-47 Chinook.

Following a joint investigation by the FBI and the Drug Enforcement Administration, dozens of Boeing employees have been charged with, and many convicted of, either distributing or attempting to illegally possess prescription drugs at Boeing’s Ridley Park facility between 2007 and 2011. As sentencing approaches for those convicted of attempted possession of illegal prescription drugs, defendants William Wallace Wilson, Andy Duris, Michael Homer, Jeffrey Lynn Forbes, Thomas Alfred Lees, Vincent Joseph Demsky, George Anthony Torres, III, James Swan, John Francis Shalkowski, Michael Patterson, Victor Phillip, and William Brian Summers seek special pre-judgment probation under 18 U.S.C. § 3607(a).2 This unique statute allows first-time, misdemeanor drug offenders to obtain dismissal of the proceedings upon successful completion of a probationary term lasting up to one year.

The government has filed a blanket opposition to all § 3607 requests and urges me to exercise my broad discretion to deny special probation to all Boeing defendants for a variety of reasons, primarily the critical role the company and its employees play in our national defense. During a [678]*678two-day hearing on the pending motions, the government offered testimony by eight witnesses, including Agent Carr, Boeing employees, and cooperating defendants who used and sold prescription drugs at the Ridley Park facility. Counsel agree that the requests of Duris, Swan, Patterson, and Phillip are now ripe for consideration.3 For the reasons that follow, I will grant the requests of Duris and Phillip, but deny the requests of Swan and Patterson.

Our nation has long struggled to reconcile its war-time patriotism and quest for national security with its need to safeguard individual liberty, due process, and a sense of fairness. See Boumediene v. Bush, 553 U.S. 723, 128 S.Ct. 2229, 171 L.Ed.2d 41 (2008) (ruling Military Commission Act unconstitutional and granting Guantanamo Bay detainees habeas corpus privileges); Korematsu v. United States, 323 U.S. 214, 65 S.Ct. 193, 89 L.Ed. 194 (1944) (upholding order requiring Japanese-Americans in “military areas” on the west coast to evacuate their homes and submit to military control); Schenck v. United States, 249 U.S. 47, 52, 39 S.Ct. 247, 63 L.Ed. 470 (1919) (finding the right to free speech to be limited during World War I, reasoning “[w]hen a nation is at war many things that might be said in time of peace are such a hindrance to its effort that their utterance will not be endured”). As explained further below, a blanket denial of special probation to a class of defendants working in the defense industry is inconsistent with the principle of individualized sentencing. See 18 U.S.C. § 3553(a). This is especially critical here, because the government has offered little evidence that any individual offenders jeopardized national security by producing defective weaponry, or were cited for poor work performance at Boeing. The critical role of Boeing’s work in our national defense is only one factor in the § 3607 determination; it cannot serve as a talisman that overrides the intent of Congress to afford first-time, misdemeanor drug offenders a rare opportunity for redemption.

I must consider the individual circumstances of each defendant in the larger context of drug abuse at Boeing. For example, some defendants became unwittingly addicted to pain medication following surgery or serious injury, have led otherwise crime-free lives, and performed years of unblemished service at Boeing. Their cases fall squarely within the heartland of what Congress envisioned when it enacted § 3607. Others, however, merit denial because they abused leadership positions at Boeing, sold drugs for profit, continued to offend after receiving an opportunity for redemption through a state or local first-time-offenders program, or refused to confront the serious nature of their crimes.

FACTUAL BACKGROUND 4

Like most companies, Boeing has a policy prohibiting the use, possession, and sale of controlled substances and drug paraphernalia on its property. Employees are subject to drug testing based on “reasonable suspicion” and after involvement in serious accidents.5 Boeing does not fire an [679]*679employee after a positive drug test. Rather, the worker receives a Compliance Notification Memorandum placing conditions on his continued employment, which remain in effect for three years and include drug treatment pursuant to a Substance Abuse Recovery Plan,6 Similarly, an employee facing termination based on attendance or work quality problems is permitted to keep his job with Boeing if he voluntarily admits the problems stem from substance abuse and successfully completes drug treatment. In these instances, the company is aware of, and monitors, the employee’s treatment.

Boeing’s drug policy also includes a generous Employee Assistance Program (“EAP”), which permits workers to voluntarily, confidentially, and at the company’s expense, seek treatment for substance abuse issues. An employee who avails himself of drug treatment through EAP retains his job and may collect disability benefits — also at the company’s expense— if he seeks them. Neither Boeing nor any future employers are made aware of the employee’s problem or treatment. There is no limit on the number of times an employee may utilize EAP services. Signs and posters designed to remind employees of the EAP and its purpose were included on both Boeing and UAW billboards throughout the Ridley Park facility.

Robert Fasold, a former police detective, has been the director of corporate security at Boeing’s Ridley Park facility since 2003. By 2005, based on tips from employees, a number of on-the-job assaults and accidents, a scrap-metal theft problem, and drug paraphernalia he recovered in work areas, Fasold suspected there was widespread drug abuse among workers at the facility.7

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Nunez-Reyes v. Holder
646 F.3d 684 (Ninth Circuit, 2010)
Schenck v. United States
249 U.S. 47 (Supreme Court, 1919)
Korematsu v. United States
323 U.S. 214 (Supreme Court, 1945)
Boumediene v. Bush
553 U.S. 723 (Supreme Court, 2008)
United States v. Delfino Lomeli Gonzalez
365 F.3d 796 (Ninth Circuit, 2004)
United States v. Daniel Voelker
489 F.3d 139 (Third Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
881 F. Supp. 2d 675, 2012 U.S. Dist. LEXIS 107325, 2012 WL 3114728, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-duris-paed-2012.